ArticleProceedings of the National Academy of Sciences of the United States of America2007

Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease.

Manuel Aivado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.